Evidence map›Paper›PMID 37328105›Full record

ArticleThe Journal of biological chemistry2023

SAMHD1 impairs type I interferon induction through the MAVS, IKKε, and IRF7 signaling axis during viral infection.

Constanza E Espada, Levent Sari, Michael P Cahill, Hua Yang, Stacia Phillips, Nicholas Martinez, Adam D Kenney, Jacob S Yount, Yong Xiong, Milo M Lin and 1 more

Open access · goldAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
2.0field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 12 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Review
  6. Article
  7. Article
  8. Review
  9. Article
  10. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 5 institutions in 1 country.

Constanza E EspadaDepartment of Microbiology and Immunology, Carver College of Medicine, University of Iowa, Iowa City, Iowa, USA.
Levent SariLyda Hill Department of Bioinformatics, University of Texas Southwestern Medical Center, Dallas, Texas, USA.
Michael P CahillDepartment of Microbiology and Immunology, Carver College of Medicine, University of Iowa, Iowa City, Iowa, USA.
Hua YangDepartment of Microbiology and Immunology, Carver College of Medicine, University of Iowa, Iowa City, Iowa, USA.
Stacia PhillipsDepartment of Microbiology and Immunology, Carver College of Medicine, University of Iowa, Iowa City, Iowa, USA.
Nicholas MartinezDepartment of Molecular Biophysics and Biochemistry, Yale University, New Haven, Connecticut, USA.
Adam D KenneyDepartment of Microbial Infection and Immunity, The Ohio State University, Columbus, Ohio, USA.
Jacob S YountDepartment of Microbial Infection and Immunity, The Ohio State University, Columbus, Ohio, USA.
Yong XiongDepartment of Molecular Biophysics and Biochemistry, Yale University, New Haven, Connecticut, USA.
Milo M LinLyda Hill Department of Bioinformatics, University of Texas Southwestern Medical Center, Dallas, Texas, USA. Electronic address: Milo.Lin@UTSouthwestern.edu.
Li WuDepartment of Microbiology and Immunology, Carver College of Medicine, University of Iowa, Iowa City, Iowa, USA. Electronic address: li-wu@uiowa.edu.
University of Iowa · USThe Ohio State University · USYale University · USSouthwestern Medical Center · USThe University of Texas Southwestern Medical Center · US

Funding

Mechanisms of innate resistance to virus infectionsR01AI130110 · NIAID · OHIO STATE UNIVERSITY · PI Jacob Yount · 2017 to 2026
$4.3M
Mechanisms of lung and cardiac pathology in SARS-CoV-2 infectionsR01HL168501 · NHLBI · OHIO STATE UNIVERSITY · PI Amal O Amer, Jacob Yount · 2023 to 2026
$2.9M
Protein therapy to treat virus induced cardiopulmonary injuryR01HL157215 · NHLBI · UNIVERSITY OF VIRGINIA · PI CAI, CHUANXI, MA, JIANJIE · 2022 to 2025
$2.7M
Mechanistic characterization of a new master regulator of cardiac virus infectionsR01HL154001 · NHLBI · OHIO STATE UNIVERSITY · PI ACCORNERO, FEDERICA, YOUNT, JACOB · 2020 to 2023
$2.3M
Targeting HIV-1 RNA modifications in latently infected CD4+ T cells for therapeutic developmentR61AI169659 · NIAID · UNIVERSITY OF IOWA · PI WU, LI · 2022 to 2024
$2.2M
SAMHD1-mediated regulation of HIV-1 innate immunity and viral gene expressionR01AI141495 · NIAID · UNIVERSITY OF IOWA · PI WU, LI · 2019 to 2023
$1.9M
Interdisciplinary Program in Microbe-Host BiologyT32AI165391 · NIAID · OHIO STATE UNIVERSITY · PI RAJENDAR K DEORA, Daniel J Wozniak · 2022 to 2026
$1.5M
HIV-1-induced upregulation of m6A modifications of cellular RNA in CD4+ T-cellsR21AI170070 · NIAID · UNIVERSITY OF IOWA · PI PHILLIPS, STACIA L, WU, LI · 2022 to 2023
$425k
NHLBI NIH HHS R01 HL154001NHLBI NIH HHS R01 HL157215NHLBI NIH HHS R01 HL168501NIAID NIH HHS R01 AI130110NIAID NIH HHS R01 AI141495NIAID NIH HHS R21 AI170070NIAID NIH HHS R61 AI169659NIAID NIH HHS T32 AI165391
6 · The paper itself

Abstract

Sterile alpha motif and HD domain-containing protein 1 (SAMHD1) restricts human immunodeficiency virus type 1 (HIV-1) infection by reducing the intracellular dNTP pool. We have shown that SAMHD1 suppresses nuclear factor kappa-B activation and type I interferon (IFN-I) induction by viral infection and inflammatory stimuli. However, the mechanism by which SAMHD1 inhibits IFN-I remains unclear. Here, we show that SAMHD1 inhibits IFN-I activation induced by the mitochondrial antiviral-signaling protein (MAVS). SAMHD1 interacted with MAVS and suppressed MAVS aggregation in response to Sendai virus infection in human monocytic THP-1 cells. This resulted in increased phosphorylation of TANK binding kinase 1 (TBK1), inhibitor of nuclear factor kappa-B kinase epsilon (IKKε), and IFN regulatory factor 3 (IRF3). SAMHD1 suppressed IFN-I activation induced by IKKε and prevented IRF7 binding to the kinase domain of IKKε. We found that SAMHD1 interaction with the inhibitory domain (ID) of IRF7 (IRF7-ID) was necessary and sufficient for SAMHD1 suppression of IRF7-mediated IFN-I activation in HEK293T cells. Computational docking and molecular dynamics simulations revealed possible binding sites between IRF7-ID and full-length SAMHD1. Individual substitution of F411, E416, or V460 in IRF7-ID significantly reduced IRF7 transactivation activity and SAMHD1 binding. Furthermore, we investigated the role of SAMHD1 inhibition of IRF7-mediated IFN-I induction during HIV-1 infection. We found that THP-1 cells lacking IRF7 expression had reduced HIV-1 infection and viral transcription compared to control cells, indicating a positive role of IRF7 in HIV-1 infection. Our findings suggest that SAMHD1 suppresses IFN-I induction through the MAVS, IKKε, and IRF7 signaling axis.

Indexed as

HIV InfectionsInterferon Type ISAM Domain and HD Domain-Containing Protein 1Adaptor Proteins, Signal TransducingHEK293 CellsHumansI-kappa B KinaseImmunity, InnateInterferon Regulatory Factor-3Interferon Regulatory Factor-7Signal TransductionAdaptor Proteins, Signal TransducingI-kappa B KinaseInterferon Regulatory Factor-3Interferon Regulatory Factor-7Interferon Type IIRF3 protein, humanIRF7 protein, humanMAVS protein, humanSAM Domain and HD Domain-Containing Protein 1SAMHD1 protein, humanHIV-1IKKεinnate immunityinterferonIRFMAVSmolecular dockingSAMHD1

Identifiers

PMID37328105
PMCPMC10404699
OpenAlexW4380786774

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.